Tag: BioNTech

Mainz-based biotechnology firm BioNTech, once celebrated as a pandemic-era vaccine champion, is executing a strategic pivot with billion-dollar implications. As ...

BioNTech has achieved a critical milestone in its oncology program, marking a significant advancement beyond its COVID-19 vaccine business. The ...

BioNTech SE has achieved a significant milestone in its oncology pipeline, sending its stock price sharply higher. The Mainz-based biotechnology ...

BioNTech SE has achieved a significant milestone in its oncology pipeline, with a novel breast cancer therapy demonstrating superior results ...

German biotechnology firm BioNTech has announced a significant advancement in its oncology pipeline, marking a pivotal achievement beyond its renowned ...

A significant regulatory milestone achieved by Mainz-based biotechnology firm BioNTech in late August has reignited investor optimism. The U.S. Food ...

BioNTech SE is executing a remarkable strategic transformation, evolving from its pandemic-era identity into a diversified biotechnology powerhouse. This shift ...

After a prolonged period of decline, investors in BioNTech SE may finally have reasons for optimism. A trio of significant ...

Shares of German biotech firm BioNTech SE came under intense pressure following concerning reports from the United States regarding a ...

BioNTech is executing a fundamental strategic realignment, moving decisively away from its pandemic-related business toward an intensified focus on cancer ...